EUR 75.75
(-3.13%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 918.96 Million EUR | -17.08% |
2022 | 1.1 Billion EUR | 8.69% |
2021 | 1.01 Billion EUR | 6.51% |
2020 | 957.33 Million EUR | 2.91% |
2019 | 930.22 Million EUR | 5.17% |
2018 | 884.49 Million EUR | 24.52% |
2017 | 710.32 Million EUR | -9.52% |
2016 | 785.08 Million EUR | -10.09% |
2015 | 873.15 Million EUR | 109.25% |
2014 | 417.27 Million EUR | 3.56% |
2013 | 402.93 Million EUR | 6.89% |
2012 | 376.95 Million EUR | 386.8% |
2011 | -131.43 Million EUR | -117.08% |
2010 | -60.54 Million EUR | -7.85% |
2009 | -56.13 Million EUR | 40.51% |
2008 | -94.36 Million EUR | -123.85% |
2007 | 395.68 Million EUR | 1687.95% |
2006 | -24.91 Million EUR | 13.68% |
2005 | -28.86 Million EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 1.01 Billion EUR | 9.94% |
2024 Q2 | 1.09 Billion EUR | 8.61% |
2024 Q3 | 1.15 Billion EUR | 4.81% |
2023 Q3 | 970.02 Million EUR | -2.21% |
2023 FY | 918.96 Million EUR | -17.08% |
2023 Q1 | 1.21 Billion EUR | 9.76% |
2023 Q2 | 991.97 Million EUR | -18.44% |
2023 Q4 | 918.96 Million EUR | -5.26% |
2022 Q3 | 1.17 Billion EUR | 1.85% |
2022 Q4 | 1.1 Billion EUR | -5.44% |
2022 FY | 1.1 Billion EUR | 8.69% |
2022 Q1 | 1.09 Billion EUR | 7.24% |
2022 Q2 | 1.15 Billion EUR | 5.24% |
2021 Q1 | 1.02 Billion EUR | 6.98% |
2021 Q3 | 1.06 Billion EUR | 1.29% |
2021 FY | 1.01 Billion EUR | 6.51% |
2021 Q4 | 1.01 Billion EUR | -4.62% |
2021 Q2 | 1.05 Billion EUR | 3.04% |
2020 FY | 957.33 Million EUR | 2.91% |
2020 Q1 | 1.05 Billion EUR | 13.47% |
2020 Q4 | 957.33 Million EUR | -6.4% |
2020 Q3 | 1.02 Billion EUR | 0.53% |
2020 Q2 | 1.01 Billion EUR | -3.61% |
2019 Q3 | 1.01 Billion EUR | 4.51% |
2019 Q1 | 997.44 Million EUR | 12.77% |
2019 FY | 930.22 Million EUR | 5.17% |
2019 Q2 | 975.45 Million EUR | -2.2% |
2019 Q4 | 930.22 Million EUR | -8.75% |
2018 Q2 | 797.02 Million EUR | 5.84% |
2018 FY | 884.49 Million EUR | 24.52% |
2018 Q4 | 884.49 Million EUR | -19.74% |
2018 Q3 | 1.1 Billion EUR | 38.27% |
2018 Q1 | 753.03 Million EUR | 6.01% |
2017 Q1 | 817.71 Million EUR | 4.16% |
2017 FY | 710.32 Million EUR | -9.52% |
2017 Q4 | 710.32 Million EUR | -9.89% |
2017 Q3 | 788.25 Million EUR | -4.94% |
2017 Q2 | 829.21 Million EUR | 1.41% |
2016 FY | 785.08 Million EUR | -10.09% |
2016 Q3 | 890.92 Million EUR | -2.64% |
2016 Q2 | 915.1 Million EUR | -0.37% |
2016 Q1 | 918.47 Million EUR | 5.19% |
2016 Q4 | 785.08 Million EUR | -11.88% |
2015 Q3 | 458.13 Million EUR | -4.33% |
2015 Q4 | 873.15 Million EUR | 90.59% |
2015 Q2 | 478.89 Million EUR | 2.67% |
2015 Q1 | 466.45 Million EUR | 11.79% |
2015 FY | 873.15 Million EUR | 109.25% |
2014 Q4 | 417.27 Million EUR | -12.4% |
2014 Q3 | 476.31 Million EUR | -0.95% |
2014 Q2 | 480.88 Million EUR | 5.15% |
2014 Q1 | 457.31 Million EUR | 13.5% |
2014 FY | 417.27 Million EUR | 3.56% |
2013 Q4 | 402.93 Million EUR | -15.68% |
2013 Q3 | 477.85 Million EUR | -0.58% |
2013 Q2 | 480.66 Million EUR | 2.54% |
2013 Q1 | 468.73 Million EUR | 24.35% |
2013 FY | 402.93 Million EUR | 6.89% |
2012 Q2 | -65.07 Million EUR | 40.14% |
2012 FY | 376.95 Million EUR | 386.8% |
2012 Q4 | 376.95 Million EUR | 589.14% |
2012 Q3 | -77.06 Million EUR | -18.43% |
2012 Q1 | -108.71 Million EUR | -129.1% |
2011 FY | -131.43 Million EUR | -117.08% |
2011 Q3 | -112.01 Million EUR | -28.29% |
2011 Q2 | -87.31 Million EUR | -91.41% |
2011 Q4 | 373.63 Million EUR | 433.55% |
2011 Q1 | -45.61 Million EUR | 24.66% |
2010 FY | -60.54 Million EUR | -7.85% |
2010 Q4 | -60.54 Million EUR | -15.32% |
2010 Q3 | -52.5 Million EUR | -25.24% |
2010 Q2 | -41.92 Million EUR | -4.26% |
2010 Q1 | -40.21 Million EUR | 28.37% |
2009 FY | -56.13 Million EUR | 40.51% |
2009 Q4 | -56.13 Million EUR | 0.0% |
2008 FY | -94.36 Million EUR | -123.85% |
2007 FY | 395.68 Million EUR | 1687.95% |
2006 FY | -24.91 Million EUR | 13.68% |
2005 FY | -28.86 Million EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 47.97 Million EUR | -1815.556% |
Carl Zeiss Meditec AG | 145.09 Million EUR | -533.357% |
Fielmann Aktiengesellschaft | 593.44 Million EUR | -54.853% |
Sartorius Aktiengesellschaft | 4.93 Billion EUR | 81.368% |
Sartorius Aktiengesellschaft | 4.93 Billion EUR | 81.368% |